Andrew D. Ellington

The University of Texas at Austin, Institut de Biologie Moléculaire et Cellulaire

Papers

Total Citations

269

H-Index

About

Andrew D. Ellington is a pioneering molecular biologist whose research has fundamentally advanced the fields of in vitro selection, aptamer technology, and laboratory automation. Best known for his groundbreaking work on RNA and DNA aptamers — short nucleic acid sequences capable of binding specific target molecules with remarkable precision — Ellington has helped transform how researchers identify and deploy molecular recognition tools for diagnostic and therapeutic applications. His most influential contribution, "Automated RNA Selection" (1998, 155 citations), revolutionized the traditionally labor-intensive SELEX process by engineering a robotic, high-throughput platform capable of generating aptamers against targets ranging from small ions to whole cells. This innovation dramatically accelerated aptamer discovery and laid the groundwork for scalable nucleic acid selection pipelines. Building on this, his work on functional RNA microarrays (2004, 87 citations) enabled high-throughput antiprotein aptamer screening, further expanding the toolkit available to molecular biologists and drug developers. Ellington's career reflects a sustained commitment to merging molecular biology with automation and systems-level thinking, from nucleic acid enzyme selection to cell phenotyping microarrays. His cumulative citation record underscores his lasting influence on how the scientific community approaches nucleic acid engineering, making him an essential figure for any researcher entering the aptamer or synthetic biology space.